Skip to main content
Caplight Logo









AccurKardia

AccurKardia

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.accurkardia.com/

Last Round

Seed

Jun 20, 2023

Total Funding Raised

$2.7M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

AccurKardia is a medical software company that provides an automated, clinical-grade electrocardiogram (ECG) interpretation software platform for cardiac monitoring.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Medical Devices

Business Model

B2B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

ECG analysiscardiac arrhythmia detectionmedical AIremote patient monitoringdevice-agnostic softwareclinical decision supportelectrocardiogramECGFDA-cleared softwarecardiology AIdiagnostic softwareusage-based SaaScardiac monitoringAI diagnosticsdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AccurKardia Comparables

Compare AccurKardia with similar companies based on industry and business-model similarity.

AccurKardia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cardiomatics
92%
Idoven
86%
Powerful Medical
84%

AccurKardia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 20, 2023

Key People

Founding team and executive leadership

Mohamed Sadeq Ali

Co-founder & Chief Operating Officer

Founding Team

Juan C Jimenez

Co-Founder and CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 29, 2026

    Grew 26% QoQ, from 19 to 24 employees.

  • Jul 26, 2026

    Monthly visitors grew 861% MoM, reaching 4.1K.

Recent news

Latest coverage and updates

  • partners_withJul 9, 2026

    AccurKardia, Inc. partnered with Wellysis Corp. on Jul 9th '26.

AccurKardia Filings

Explore SEC and related filing metadata, where available.

AccurKardia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AccurKardia's valuation, stock price, and market status.

Is AccurKardia a public or private company?

AccurKardia is a private company.

What is the current stock price of AccurKardia?

AccurKardia is a private company with no public stock price. No recent secondary market data is available.

How much is AccurKardia worth (valuation)?

Valuation information for AccurKardia is not publicly available.

Can I buy AccurKardia stock?

AccurKardia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AccurKardia's last funding round?

AccurKardia's most recent funding round was Seed on June 20, 2023.

Who are the main investors in AccurKardia?

Investor information for AccurKardia is not publicly disclosed.

Will AccurKardia IPO soon?

No public IPO plans have been announced for AccurKardia.

How can I track AccurKardia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AccurKardia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range20
Year Founded2019
Last FundingJun 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?